Safety of new medicines in young children

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 872-873

  Choonara, Imti ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; CHLORAMPHENICOL; ORCIPRENALINE; PROPOFOL; RIMONABANT; ROFECOXIB; ROSIGLITAZONE; VALPROIC ACID; VALSARTAN;

ASTHMA; CARDIOTOXICITY; CHILD; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG INDUSTRY; DRUG METABOLISM; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HUMAN; HYPERTENSION; LIVER INJURY; LIVER TOXICITY; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; MALE;

EID: 80051806889     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300450     Document Type: Editorial

References (21)

1. Tullus K. Safety concerns of angiotensin II receptor blockers in preschool children . Arch Dis Child 2011;Published Online First: 19 June 2011 doi:10.1136/archdischild-2011-300172.
2. Sammons H.M., Gray C., Hudson H., et al. Safety in paediatric clinical trials-a 7-year review. Acta Paediatr 2008;97:474-477 (Pubitemid 351432298)
3. de Vries T.W., van Roon EN. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials. Arch Dis Child 2009;95:1023-1026
4. Tsang R., Colley L, Lynd LD. Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials. J Clin Epidemiol 2009;62:609-616
5. Sutherland J.M. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child 1959;97:13-19.
6. Weiss C.F., Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med 1960;262:787-794
7. Dreifuss F.E., Santilli N., Langer D.H., et al. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987;37:379-385 (Pubitemid 17031731)
8. Parke T.J., Stevens J.E., Rice A.S., et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992;305:613-616
9. Bray R.J. Propofol infusion syndrome in children. Paediatr Anaesth 1998;8:491-499 (Pubitemid 28523410)
10. Impicciatore P., Pandolfini C., Bosetti C., et al. Adverse drug reactions in children: a systematic review of published case reports. Paed Perinat Drug Ther 1998;2:27-33. (Pubitemid 128774887)
11. Turner E.H., Matthews A.M., Linardatos E., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-260
12. Wieseler B., McGauran N, Kaiser T. Drug studies: a tale of hide and seek. BMJ 2010;341:809-814
13. Whittington CJ, Kendall T, Fonagy P, et al Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data Lancet 2004;363:1341-5.
14. Dieppe P.A., Ebrahim S., Martin R.M., et al. Lessons from the withdrawal of rofecoxib. BMJ 2004;329:867-868 (Pubitemid 39422926)
15. Jüni P., Nartey L., Reichenbach S., et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-2029 (Pubitemid 39593078)
16. Psaty B.M., Kronmal RA. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA 2008;299:1813-1817 (Pubitemid 351549972)
17. Medicines Health Regulatory Agency. Rimonabant: European suspension of marketing authorisation. Drug Safety Update 2008;2:8.
18. Medicines Health Regulatory Agency. Orciprenaline sulphate (Alupent): withdrawal due to unfavourable benefit-risk profile. Drug Safety Update 2009;3:6.
19. Medicines Health Regulatory Agency. Rosiglitazone: recommended withdrawal from clinical use. Drug Safety Update 2010;4:S1.
20. Choonara I., Rieder MJ. Drug toxicity and adverse drug reactions in children-a brief historical review. Paed Perinat Drug Ther 2002;5:12-18. (Pubitemid 34966670)
21. Kahn A., Hasaerts D, Blum D. Phenothiazine-induced sleep apneas in normal infants. Pediatrics 1985;75:844-847 (Pubitemid 15054311)